<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments for MediStem Inc.</title>
	<atom:link href="http://medisteminc.com/comments/feed/" rel="self" type="application/rss+xml" />
	<link>http://medisteminc.com</link>
	<description>Endometrial Regenerative Cells</description>
	<lastBuildDate>Tue, 27 Mar 2012 21:10:24 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
	<item>
		<title>Comment on Medistem Inc. to Add Kidney and Lung Failure to Clinical Trials of Endometrial Regenerative Cells (ERC) Stem Cells in Russia by Medistem signs license with Yale University to develop stem-cell treatment for type 1 diabetes - San Diego Biotechnology Connection &#124; San Diego Biotechnology Connection</title>
		<link>http://medisteminc.com/2012/medistem-inc-to-add-kidney-and-lung-failure-to-clinical-trials-of-endometrial-regenerative-cells-erc-stem-cells-in-russia/#comment-34</link>
		<dc:creator>Medistem signs license with Yale University to develop stem-cell treatment for type 1 diabetes - San Diego Biotechnology Connection &#124; San Diego Biotechnology Connection</dc:creator>
		<pubDate>Tue, 27 Mar 2012 21:10:24 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=512#comment-34</guid>
		<description>[...] Medistem adds kidney and lung dailure to xlinical trials of Stem Cells in Russia [...]</description>
		<content:encoded><![CDATA[<p>[...] Medistem adds kidney and lung dailure to xlinical trials of Stem Cells in Russia [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical Trials by Medistem signs license with Yale University to develop stem-cell treatment for type 1 diabetes - San Diego Biotechnology Connection &#124; San Diego Biotechnology Connection</title>
		<link>http://medisteminc.com/2012/stem-cell-pioneers-converge-in-portland-to-discuss-and-celebrate-a-revolutionary-new-stem-cell-entering-human-clinical-trials/#comment-33</link>
		<dc:creator>Medistem signs license with Yale University to develop stem-cell treatment for type 1 diabetes - San Diego Biotechnology Connection &#124; San Diego Biotechnology Connection</dc:creator>
		<pubDate>Tue, 27 Mar 2012 21:09:01 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=509#comment-33</guid>
		<description>[...] Stem-cell pioneers converge in Portland to discuss new human stem-cell clinical trials [...]</description>
		<content:encoded><![CDATA[<p>[...] Stem-cell pioneers converge in Portland to discuss new human stem-cell clinical trials [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Medistem Inc. Annual Letter to Shareholders by Thomas Ichim</title>
		<link>http://medisteminc.com/2011/medistem-inc-annual-letter-to-shareholders/#comment-31</link>
		<dc:creator>Thomas Ichim</dc:creator>
		<pubDate>Wed, 21 Mar 2012 02:55:19 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=463#comment-31</guid>
		<description>Dear Mike,

Thank you for your message.  Medistem is a non-reporting PINKSHEETS company after our voluntary delisting in January 2009.  As such, the year end financials are not publicly available.  If you have an interest in the company, we can sign a CDA and discuss this with you.

Best wishes

Tom

Thomas E Ichim,
Chief Executive Officer
Medistem Inc
9255 Towne Centre Drive
Suite 450
San Diego
CA 92121
858 349 3617 
858 642 0027
thomas.ichim[at]medisteminc.com</description>
		<content:encoded><![CDATA[<p>Dear Mike,</p>
<p>Thank you for your message.  Medistem is a non-reporting PINKSHEETS company after our voluntary delisting in January 2009.  As such, the year end financials are not publicly available.  If you have an interest in the company, we can sign a CDA and discuss this with you.</p>
<p>Best wishes</p>
<p>Tom</p>
<p>Thomas E Ichim,<br />
Chief Executive Officer<br />
Medistem Inc<br />
9255 Towne Centre Drive<br />
Suite 450<br />
San Diego<br />
CA 92121<br />
858 349 3617<br />
858 642 0027<br />
thomas.ichim[at]medisteminc.com</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Medistem Inc. to Add Kidney and Lung Failure to Clinical Trials of Endometrial Regenerative Cells (ERC) Stem Cells in Russia by Rajendra Bengani</title>
		<link>http://medisteminc.com/2012/medistem-inc-to-add-kidney-and-lung-failure-to-clinical-trials-of-endometrial-regenerative-cells-erc-stem-cells-in-russia/#comment-30</link>
		<dc:creator>Rajendra Bengani</dc:creator>
		<pubDate>Tue, 13 Mar 2012 06:27:17 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=512#comment-30</guid>
		<description>Is there any clinical trail/treatment of Pulmonary Hypertension (PAH) of Lungs and also Hypoplastic Lungs ? If any one can help, plz send details. I am from New Delhi, INDIA</description>
		<content:encoded><![CDATA[<p>Is there any clinical trail/treatment of Pulmonary Hypertension (PAH) of Lungs and also Hypoplastic Lungs ? If any one can help, plz send details. I am from New Delhi, INDIA</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Evening with Medistem &#8211; March 7, 2012 by Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical Trials — MediStem Inc.</title>
		<link>http://medisteminc.com/evening-with-medistem-march-7-2012/#comment-25</link>
		<dc:creator>Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical Trials — MediStem Inc.</dc:creator>
		<pubDate>Tue, 28 Feb 2012 20:10:47 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?page_id=496#comment-25</guid>
		<description>[...] Portland, OR &#8211; 3/7/ 2012 [...]</description>
		<content:encoded><![CDATA[<p>[...] Portland, OR &#8211; 3/7/ 2012 [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Medistem Inc. Annual Letter to Shareholders by Mike Camosy</title>
		<link>http://medisteminc.com/2011/medistem-inc-annual-letter-to-shareholders/#comment-23</link>
		<dc:creator>Mike Camosy</dc:creator>
		<pubDate>Fri, 24 Feb 2012 03:43:45 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=463#comment-23</guid>
		<description>Hello,

I have been reviewing your company and a impressed with what I have learned so far.  However, I can&#039;t seem to find any financial information regarding this company on your website.  I am considering becoming an investor, but would like to understand the financial picture before purchasing shares.  Please tell me where I can find your year end financials for 2011.

Thank You,

Mike Camosy</description>
		<content:encoded><![CDATA[<p>Hello,</p>
<p>I have been reviewing your company and a impressed with what I have learned so far.  However, I can&#8217;t seem to find any financial information regarding this company on your website.  I am considering becoming an investor, but would like to understand the financial picture before purchasing shares.  Please tell me where I can find your year end financials for 2011.</p>
<p>Thank You,</p>
<p>Mike Camosy</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on MSNBC &#8211; Menstrual blood tapped as source of stem cells by Anonymous</title>
		<link>http://medisteminc.com/2007/msnbc-menstrual-blood-tapped-as-source-of-stem-cells/#comment-22</link>
		<dc:creator>Anonymous</dc:creator>
		<pubDate>Wed, 22 Feb 2012 15:22:05 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=301#comment-22</guid>
		<description>[...]  [...]</description>
		<content:encoded><![CDATA[<p>[...]  [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Medistem Initiates Collaboration With Chinese Conglomerate Aimed at Clinical Development of Endometrial Regenerative Cells for Critical Limb Ischemia by Medistem Initiates Collaboration With Chinese Conglomerate Aimed at Clinical Development of Endometrial Regenerative Cells for Critical Limb Ischemia</title>
		<link>http://medisteminc.com/2012/medistem-initiates-collaboration-with-chinese-conglomerate-aimed-at-clinical-development-of-endometrial-regenerative-cells-for-critical-limb-ischemia/#comment-21</link>
		<dc:creator>Medistem Initiates Collaboration With Chinese Conglomerate Aimed at Clinical Development of Endometrial Regenerative Cells for Critical Limb Ischemia</dc:creator>
		<pubDate>Tue, 21 Feb 2012 13:49:02 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=491#comment-21</guid>
		<description>[...]  [...]</description>
		<content:encoded><![CDATA[<p>[...]  [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Benitec Biopharma and Medistem Technologies Successfully Combined in Preclinical Stem Cell Therapy for Rheumatoid Arthritis by Benitec Biopharma and Medistem Technologies Successfully Combined in Preclinical Stem Cell Therapy for Rheumatoid Arthritis</title>
		<link>http://medisteminc.com/2012/benitec-biopharma-and-medistem-technologies-successfully-combined-in-preclinical-stem-cell-therapy-for-rheumatoid-arthritis/#comment-20</link>
		<dc:creator>Benitec Biopharma and Medistem Technologies Successfully Combined in Preclinical Stem Cell Therapy for Rheumatoid Arthritis</dc:creator>
		<pubDate>Tue, 21 Feb 2012 13:43:52 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=488#comment-20</guid>
		<description>[...]  [...]</description>
		<content:encoded><![CDATA[<p>[...]  [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Rheumatoid Arthritis Patient Success Using Adult Stem Cell Protocol by C</title>
		<link>http://medisteminc.com/2010/rheumatoid-arthritis-patient-success-using-adult-stem-cell-protocol/#comment-17</link>
		<dc:creator>C</dc:creator>
		<pubDate>Wed, 01 Feb 2012 15:28:18 +0000</pubDate>
		<guid isPermaLink="false">http://medisteminc.com/?p=111#comment-17</guid>
		<description>How do we get the treatment</description>
		<content:encoded><![CDATA[<p>How do we get the treatment</p>
]]></content:encoded>
	</item>
</channel>
</rss>

